ALK and anaplastic large cell lymphoma: While the evidence for CHOEP is strongest in ALK-positive ALCL, BV plus CHP (cyclophosphamide, doxorubicin, and prednisolone) has largely replaced its use based on the ECHELO-2 study [9].